Navigation Links
NW Bio's International Phase III GBM Brain Trial Is Subject Of BBC TV Report In The UK
Date:12/30/2013

BETHESDA, Md., Dec. 30, 2013 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network has broadcast a report profiling the first European patient in the Company's Phase III clinical trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM), the most common and aggressive form of brain cancer.  This patient was operated on in June, 2013, by Dr. Keyoumars Ashkan, a senior neurosurgeon at Kings College Hospital and the lead investigator for the trial in the U.K., to remove his brain tumor and enable him to enter the DCVax-L trial.

(Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

The BBC report can be seen at http://www.bbc.co.uk/news/health-25499045. The BBC report notes that immune therapies are emerging as one of the most important areas in cancer research, and that the Phase III trial of DCVax-L for GBM is one of the most advanced involving personalized immune therapies.  The profiled patient is well known British Shakespearean actor Robert Demeger, who has appeared regularly on the stage and in the popular TV series Doctor Who.  A further interview of Mr. Demeger can also be found on the BBC website (see "Related Videos" at the same link), in which Mr. Demeger describes in more detail his own condition and circumstances.

As noted by Dr. Ashkan in the BBC report, there is substantial variation among patients with the "same" GBM brain cancer.  One-size-fits-all treatments cannot address this patient-to-patient variation.  Personalized treatments are needed in order to
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
4. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
5. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
6. Neurocrine Biosciences Reports First Quarter 2012 Results
7. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
8. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
9. BioSurplus Announces Launch of Depot Service for Agilent and AKTA HPLCs
10. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
11. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Diabetes Care, American Association of Diabetes Educators, ... Asante Solutions, A. Menarini, Bayer Group, Bayer ... Centres for Medicare and Medicaid Services ( ... Control and Prevention (CDC), Carlyle Group, Cascade ... Covidien, Cygnus, ConvaTec, Constitution Medical Investor, Dexcom, ...
(Date:3/1/2015)... /CNW Telbec/ -   Ergoresearch Ltd (TSXV: ERG) – ... under the « Équilibre, orthèses et biomécanique» banner ... on December 31, 2014. All dollar amounts in the ... Revenues for the second quarter of fiscal year 2015 ... by 8,8 % compared to revenues of $ 4 489 ...
(Date:3/1/2015)... ATLANTA , March 1, 2015  Patients ... new weapon against this debilitating foot ailment, according ... Interventional Radiology ,s Annual Scientific Meeting . ... to penetrate, emulsify and remove diseased fasciitis tissue. ... healthy tissue to regrow in its place, restoring ...
Breaking Medicine Technology:Blood Glucose Meters Industry 2019 Forecasts for Global and Chinese Regions 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 3Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 4Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3
... Dynatronics Corporation (Nasdaq: DYNT ) announced ... RB Milestone Portfolio, a group of companies selected by ... the market via a combination of traditional and innovative ... Network™, and non-deal roadshows, with a focus on the ...
... 16, 2011 McGraw-Hill Professional, a leading ... scientific and medical communities, and Simbionix™, the ... simulation technology, have partnered to bring surgical ... training resource AccessSurgery™ ( www.accesssurgery.com ) to ...
Cached Medicine Technology:Dynatronics Selected for Inclusion in RB Milestone Portfolio 2McGraw-Hill Professional and Simbionix™ Partner to Provide Enhanced Surgical Simulation and Education 2
(Date:3/1/2015)... Comparing a new source of vehicle ... Quotes Pros portal this year. A broad range of ... that are being supplied through the finder at ... prices available for each policy is now provided in ... user will first be asked to present their unique ...
(Date:3/1/2015)... March 01, 2015 A federal ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go to trial in ... a witness to provide testimony regarding the role ... of the Profemur device, Bernstein Liebhard LLP comments. ... Court, Northern District of Iowa on February 25th, ...
(Date:3/1/2015)... 01, 2015 Indiana Fiber Network, ... Provider, announces NewWays Networking, LLC (NewWays) selected IFN ... with IFN, NewWays is well positioned to scale ... for Internet bandwidth in rural parts of Indiana,” ... to Cory Childs IFN Enterprise Sales Manager, IFN ...
(Date:3/1/2015)... California (PRWEB) March 01, 2015 Theme ... a new transition pack for Final Cut ... add accordion style transitions to any FCPX editors project.” ... given our users the tools needed to easily drag ... , The user gets many different controls over the ...
(Date:2/28/2015)... February 28, 2015 In recent years Medical ... of practicing physicians as a way for them to expand ... regarding Cannabis as medicine. Since the FDA still lists Cannabis ... resources available to licensed physicians that can help guide ... Dr. Deborah Malka in Santa Cruz, CA is a ...
Breaking Medicine News(10 mins):Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2
... in Canada,s north, Canada would benefit from enhanced relationships ... CMAJ ( Canadian Medical Association Journal ) ... looks at health and health care in Canada,s north ... includes Alaska in the US, Norway, Sweden, Finland, Russia, ...
... was diagnosed in 2007 with acute multiple myeloma, a form ... troubles all those who receive an upsetting diagnosis. The way ... however, was different. Barrager drew upon his engineering and management ... is sharing his insights with hospitals and doctors in his ...
... Reporter , MONDAY, Nov. 1 (HealthDay News) -- Pain is a ... reports of pain increasing during the final few months, a new ... being "troubled" by moderate or severe pain two years before they ... had jumped to nearly half. "This study shows that ...
... , MONDAY, Nov. 1 (HealthDay News) -- The success ... fat (MUFA), which are commonly found in nuts, seeds, avocados, ... oil, new research suggests. In the study, researchers randomly ... moderate elevated cholesterol levels to either a high-MUFA diet or ...
... , MONDAY, Nov. 1 (HealthDay News) -- Stroke ... the hospital on the weekend instead of a weekday, regardless ... Canadian researchers analyzed data from almost 21,000 stroke patients ... Only patients with their first stroke were included in the ...
... National Jewish Health has received a US patent for ... help assure many patients that dramatic changes in lifestyle ... PhD, Medical Director of the Advanced Diagnostic Laboratories at ... Donald MacGlashan, Jr. developed the diagnostic assay, which makes ...
Cached Medicine News:Health News:Management science guru, surviving cancer, offers hope to fellow sufferers, doctors 2Health News:Management science guru, surviving cancer, offers hope to fellow sufferers, doctors 3Health News:Almost Half of Elderly Report Pain in Life's Final Months 2Health News:Almost Half of Elderly Report Pain in Life's Final Months 3Health News:Adding Monounsaturated Fats to Diet May Boost Heart Health 2Health News:Weekend Admissions Worse for Stroke Victims: Study 2Health News:National Jewish Health receives patent for diagnostic method of autoimmune chronic urticaria 2
Sterile perfluorocarbon for intraocular Application....
Silikon 1000 (purified polydimethylsiloxane) is a highly purified long chain polydimethylsiloxane trimethylsiloxy terminated silicone oil. For use as a postoperative retinal tamponade during vitreore...
... hard contact lens cleaning solution ... use, and professionally proven cleaner. ... detergents resulting in a very ... deposits, cosmetic residue, salts, mucous ...
4.625 inches, curved blade 4 mm....
Medicine Products: